We are excited to announce that Health Through Evidence will be participating in the upcoming ISPOR – International Society for Pharmaceutical Outcomes Research – Europe 2024 conference in Barcelona from 17-20 November!
Health Through Evidence will be presenting 15 research posters showcasing significant studies in Health Economics, Real World Evidence, and Systematic Literature Review across a diverse range of diseases.
We are deeply honored that 3 of our posters have been recognized as Top 5% Finalists for the ISPOR Europe 2024 Research Presentation Awards! 🎉 🔗 Additional details about our research posters and presentation schedules can be found below.
| Monday, 18 November 2024 | |
| 1)Title | Ivosidenib for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an IDH1 R132 mutation who were previously treated by at least one prior line of systemic therapy. A Budget Impact Analysis in Greece. |
| Authors: | Tzanetakos C, Psarra M, Chotzagiannoglou V, Beletsi A, Gourzoulidis G. |
| Poster Session Time: | 10:30 – 13:30 |
| Discussion Period: | 12:30 – 13:30 |
| Find out more at: | Study Link |
| 2)Title | Burden of Respiratory Syncytial Virus Disease in Infants and the Potential Value of Maternal Immunization in Greece. |
| Authors: | Solakidi A, Barmpouni M, Psarra M, Detsis M, Markatis E, Tzanetakos C, Gourzoulidis G. |
| Poster Session Time: | 10:30 – 13:30 |
| Discussion Period: | 12:30 – 13:30 |
| Find out more at: | Study Link |
| 3)Title | The value of vaccination in prevention of respiratory syncytial virus disease in older adults. A modelling analysis for Greece. |
| Authors: | Solakidi A, Barmpouni M, Detsis M, Markatis E, Tzanetakos C, Gourzoulidis. |
| Poster Session Time: | 10:30 – 13:30 |
| Discussion Period: | 12:30 – 13:30 |
| Find out more at: | Study Link |
| 4)Title | Retrospective non-interventional, multicenter study on the effectiveness and safety of intravesical bacillus Calmette Guerin in patients with non-muscle-invasive bladder: Real-world experience from six hospital centers in Greece. |
| Authors: | Angelopoulos P, Markopoulos T, Lazarou L, Skolarikos A, Stamatakos P, Papadopoulos I. G, Fragkoulis C, Ntoumas K, Moulavasilis N, Levis P, Papanikolaou D, Sokolakis I, Chatzimouratidis K, Tzanetakos C, Psarra M, Mavridoglou G, Skriapas K, Akrivou D, Karagiannis D, Noutsos C, Georgiou A, Hastazeris K, Gourzoulidis G, Mitropoulos D. |
| Poster Session Time: | 16:00- 19:00 |
| Discussion Period: | 18:00 -19:00 |
| Find out more at: | Study Link |
| Tuesday, 19 November 2024 | |
| 5)Title | Disease Burden and Unmet Medical Need in Patients with Crohn’s Disease in Greece: A Cross-Sectional Patient Survey. |
| Authors: | Tzanetakos C, Vakouftsi VR, Mavridoglou G, Gourzoulidis G. |
| Poster Session Time: | 10:30 – 13:30 |
| Discussion Period: | 12:30 – 13:30 |
| Find out more at: | Study Link |
| 6)Title | Treatment Preferences of Patients with Crohn’s Disease in Greece: A Cross-Sectional Patient Survey. |
| Authors: | Tzanetakos C, Vakouftsi VR, Mavridoglou G, Savourdos P, Gourzoulidis G. |
| Poster Session Time: | 10:30 – 13:30 |
| Discussion Period: | 12:30 – 13:30 |
| Find out more at: | Study Link |
| 7)Title | The Economic Burden of Lung Cancer in Greece: A Systematic Review of the Literature. |
| Authors: | Gourzoulidis G, Kastanioti C, Mavridoglou G, Kotsilieris T, Tzanetakos C. |
| Poster Session Time: | 10:30 – 13:30 |
| Discussion Period: | 12:30 – 13:30 |
| Find out more at: | Study Link |
| 8)Title | Disease Burden and Unmet Medical Need in Patients with Ulcerative Colitis in Greece: A Cross-Sectional Patient Survey.
Top 5% Finalist for the ISPOR Europe 2024 Research Presentation Awards 🏅 |
| Authors: | Gourzoulidis G, Vakouftsi VR, Mavridoglou G, Tzanetakos C. |
| Poster Session Time: | 16:00- 19:00 |
| Discussion Period: | 18:00 -19:00 |
| Find out more at: | Study Link |
| 9)Title | Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine (PCV20) to prevent pneumococcal disease in the Greek pediatric population.
Top 5% Finalist for the ISPOR Europe 2024 Research Presentation Awards 🏅 |
| Authors: | Tzanetakos C, Kokkinaki I, Barmpouni M, Kossyvaki V, Psarra M, Perdrizet J, Gourzoulidis G. |
| Poster Session Time: | 16:00- 19:00 |
| Discussion Period: | 18:00 -19:00 |
| Find out more at: | Study Link |
| 10)Title | Cost-Effectiveness Analysis of Epcoritamab for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Two or More Lines of Systemic Therapy in Greece
Top 5% Finalist for the ISPOR Europe 2024 Research Presentation Awards 🏅 |
| Authors: | Tzanetakos C, Papageorgiou G, Wang A, Psarra M, Gourzoulidis G. |
| Poster Session Time: | 16:00- 19:00 |
| Discussion Period: | 18:00 -19:00 |
| Find out more at: | Study Link |
| 11)Title | Budget Impact Analysis of Epcoritamab for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Two or More Lines of Systemic Therapy in Greece |
| Authors: | Gourzoulidis G, Papageorgiou G, Psarra M, Tzanetakos C. |
| Poster Session Time: | 16:00- 19:00 |
| Discussion Period: | 18:00 -19:00 |
| Find out more at: | Study Link |
| Wednesday, 20 November 2024 | |
| 12)Title | Patients’ Disease Burden, Satisfaction, and Use of Technology in Rheumatoid Arthritis in Greece: A Cross-Sectional Patient Survey. |
| Authors: | Tzanetakos C, Papageorgiou G, Wang A, Psarra M, Gourzoulidis G. |
| Poster Session Time: | 09:00- 11:30 |
| Discussion Period: | 09:00- 10:00 |
| Find out more at: | Study Link |
| 13)Title | Treatment Preferences of Patients with Ulcerative Colitis in Greece: A Cross-Sectional Patient Survey |
| Authors: | Tzanetakos C, Vakouftsi VR, Mavridoglou G, Savourdos P, Gourzoulidis G. |
| Poster Session Time: | 09:00- 11:30 |
| Discussion Period: | 09:00- 10:00 |
| Find out more at: | Study Link |
| 14)Title | Decision Model to Evaluate the Cost of Clinical Events Associated with Switching from Apixaban to Rivaroxaban Among Patients With Non-Valvular Atrial Fibrillation in Greece |
| Authors: | Solakidi A, Barmpouni M, Trafalis D, Antoniou Ι, Tzanetakos C, Gourzoulidis G. |
| Poster Session Time: | 09:00- 11:30 |
| Discussion Period: | 09:00- 10:00 |
| Find out more at: | Study Link |
| 15)Title | Cost-Effectiveness of Foslevodopa/Foscarbidopa for the Treatment of Advanced Parkinson’s Disease with Severe Motor Fluctuations and Hyperkinesia or Dyskinesia in Greece |
| Authors: | Tzanetakos C, Papageorgiou G, Yan CH, Boodhna T, Leoncini E, Savourdos P, Gourzoulidis G |
| Poster Session Time: | 09:00- 11:30 |
| Discussion Period: | 09:00- 10:00 |
| Find out more at: | Study Link |
Don’t miss this chance to meet the team in person. Explore how you can collaborate to drive evidence-based decisions in healthcare.
See you at ISPOR—The Professional Society for Health Economics and Outcomes Research!